1. Liu, Jian, Mai, Yumiao, Wang, Yingjie, Wei, Huixia, Yao, Qianghua. 2022. RAB3D/MDM2/β-catenin/c-MYC axis exacerbates the malignant behaviors of acute myeloid leukemia cells in vitro and in vivo. In Cancer gene therapy, 30, 335-344. doi:10.1038/s41417-022-00549-z. https://pubmed.ncbi.nlm.nih.gov/36280757/
2. Yu, Jingsong, Qi, Haipeng, Wang, Zheng, Song, Wenting, An, Ruihua. 2022. RAB3D, upregulated by aryl hydrocarbon receptor (AhR), promotes the progression of prostate cancer by activating the PI3K/AKT signaling pathway. In Cell biology international, 46, 2246-2256. doi:10.1002/cbin.11910. https://pubmed.ncbi.nlm.nih.gov/36153645/
3. Luo, Yang, Ye, Guang-Yao, Qin, Shao-Lan, Yu, Min-Hao, Zhong, Ming. 2016. High expression of Rab3D predicts poor prognosis and associates with tumor progression in colorectal cancer. In The international journal of biochemistry & cell biology, 75, 53-62. doi:10.1016/j.biocel.2016.03.017. https://pubmed.ncbi.nlm.nih.gov/27046094/
4. Limi, Saima, Ojakian, George, Raffaniello, Robert. 2012. Rab3D regulates amylase levels, not agonist-induced amylase release, in AR42J cells. In Cellular & molecular biology letters, 17, 258-73. doi:10.2478/s11658-012-0008-5. https://pubmed.ncbi.nlm.nih.gov/22367855/
5. Zhang, Jin, Kong, Ranran, Sun, Liangzhang. 2017. Silencing of Rab3D suppresses the proliferation and invasion of esophageal squamous cell carcinoma cells. In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 91, 402-407. doi:10.1016/j.biopha.2017.04.010. https://pubmed.ncbi.nlm.nih.gov/28472755/
6. Lin, Xing, Zhong, Liang, Wang, Nian, Chu, Xuan, Liu, Beizhong. 2022. Hsa_circ_0103232 promotes melanoma cells proliferation and invasion via targeting miR-661/RAB3D. In Cell cycle (Georgetown, Tex.), 21, 1811-1826. doi:10.1080/15384101.2022.2072636. https://pubmed.ncbi.nlm.nih.gov/35549813/
智鼠故事 
